Filing Details
- Accession Number:
- 0001127602-19-033377
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-20 16:27:47
- Reporting Period:
- 2019-11-18
- Accepted Time:
- 2019-11-20 16:27:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 64803 | Cvs Health Corp | CVS | Retail-Drug Stores And Proprietary Stores (5912) | 050494040 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1333760 | S Karen Lynch | One Cvs Drive Woonsocket RI 02895 | Evp & Pres, Aetna Bus Unit | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-11-18 | 80,143 | $75.00 | 41,831 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock (Restricted) | 123,455 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Appreciation Rights | $45.91 | 2019-02-17 | 2027-02-16 | 192,741 | 192,741 | Direct |
| Common Stock | Stock Appreciation Rights | $37.91 | 2019-02-19 | 2026-02-18 | 93,989 | 93,989 | Direct |
| Common Stock | Stock Option | $54.19 | 2020-04-01 | 2029-04-01 | 242,408 | 242,408 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2027-02-16 | 192,741 | 192,741 | Direct |
| 2026-02-18 | 93,989 | 93,989 | Direct |
| 2029-04-01 | 242,408 | 242,408 | Direct |
Footnotes
- All sales were effected pursuant to a Rule 10b5-1 plan.
- Represents unvested Aetna Inc. Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Aetna Plan") on February 17, 2017 that were converted into CVS Health SARs pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vest in two substantally equal annual installments beginning on February 17, 2019.
- Represents unvested SARs granted under the Aetna Plan on February 19, 2016 that were converted into CVS Health SARs pursuant to the terms of the CVS/Aetna Merger Agreement. These SARs vested on February 19, 2019.
- Option becomes exercisable in four equal annual installments, commencing 4/1/2020.
Billionaire Hedge Funds
